BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 224 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $37,053,000 | +62.1% | 330,384 | -9.5% | 0.23% | -25.9% |
Q3 2020 | $22,857,000 | -28.0% | 365,232 | -10.2% | 0.30% | +24.5% |
Q2 2020 | $31,728,000 | -99.9% | 406,773 | 0.0% | 0.24% | +7.5% |
Q1 2020 | $23,222,671,000 | -48.8% | 406,773 | -28.2% | 0.23% | -24.8% |
Q4 2019 | $45,355,558,000 | +108938.3% | 566,166 | 0.0% | 0.30% | +4.5% |
Q3 2019 | $41,596,000 | -22.1% | 566,166 | 0.0% | 0.29% | -21.0% |
Q2 2019 | $53,406,000 | +17.8% | 566,166 | 0.0% | 0.37% | +14.3% |
Q1 2019 | $45,321,000 | +48.5% | 566,166 | 0.0% | 0.32% | +24.4% |
Q4 2018 | $30,522,000 | -30.9% | 566,166 | 0.0% | 0.26% | -18.6% |
Q3 2018 | $44,194,000 | – | 566,166 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |